CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- 4 Grant or award EVP Chief Patient & Ext Af Off acquired 15,324 shares (grant or award)
- 4 Grant or award Executive Chairman acquired 15,414 shares (grant or award)
- 4 Grant or award CEO & President acquired 49,446 shares (grant or award)
- 4 Grant or award EVP and CMO acquired 16,190 shares (grant or award)
- 4 Grant or award EVP and Chief Legal Officer acquired 4,744 shares (grant or award)
- 4 Grant or award EVP, Chief Technical Ops. Off. acquired 9,876 shares (grant or award)
- 4 Grant or award EVP, COO acquired 23,072 shares (grant or award)
- 4 Grant or award SVP & Chief Accounting Officer acquired 4,420 shares (grant or award)
- 4 Grant or award EVP, Chief Scientific Officer acquired 19,428 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, Chief Scientific Officer sold 15 shares at $478.56 ($7,178)
- 4 Planned sale EVP & Chief Financial Officer sold 3,000 shares at $518.27 ($1,554,810)
- 4 Planned sale CEO & President sold 15,198 shares at $515.00 ($7,826,970)
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP and Chief Legal Officer sold 999 shares at $461.66 ($461,198)
- 4 Planned sale Executive Chairman sold 3,784 shares at $499.00 ($1,888,216)
- 4 Planned sale Director sold 646 shares at $500.00 ($323,000)
- 4 Planned sale Director sold 1,292 shares at $466.29 ($602,447)
- 4 Planned sale EVP and CMO sold 2,280 shares at $476.75 ($1,086,990)
- 4 Planned sale Director sold 5,295 shares at $508.00 ($2,689,860)
Page 11 of 129 · 2,568 filings